Author: Andritsos Leslie Khoury Hanna
Publisher: Springer Publishing Company
ISSN: 1527-2729
Source: Current Treatment Options in Oncology, Vol.3, Iss.3, 2002-06, pp. : 225-231
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Alemtuzumab in chronic lymphocytic leukemia
By James Danelle F Kipps Thomas J
Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. :
BRAF mutations in chronic lymphocytic leukemia
By Jebaraj Billy Michael Chelliah
Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. :
Recent Advances in Chronic Lymphocytic Leukemia
By Abbott Brian
Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. :
New Therapies for Chronic Lymphocytic Leukemia
Current Cancer Therapy Reviews, Vol. 9, Iss. 4, 2013-11 ,pp. :
Geography, ethnicity and “roots in chronic lymphocytic leukemia
Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. :